Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reirradiation by Nanoparticles and Hypofractionated Protontherapy of Relapsed Tumors: Non-randomized Phase II Study. (NANOPRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04784221
Recruitment Status : Not yet recruiting
First Posted : March 5, 2021
Last Update Posted : May 25, 2021
Sponsor:
Information provided by (Responsible Party):
Centre Francois Baclesse

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 2026
Estimated Study Completion Date : September 2026